Rocket Lab (NASDAQ: RKLB) is giving investors another reason to be bullish on the stock. The company just secured its largest commercial Electron launch agreement, adding years of scheduled missions and strengthening a relationship with an important customer.
For one, the company announced a multiyear agreement with Tokyo-based Synspective for 20 additional Electron launches. The missions are scheduled annually from 2028 through 2031, bringing Synspective’s total contracted Electron launches to 47, the highest number booked by any customer. Financial terms were not disclosed.
Citi Sees Major Upside for RKLB Stock
Two, Citi analyst John Godyn initiated coverage with a Buy rating and a $105 price target, describing the space company as a potential core holding for investors bullish on space. Citi highlighted the company’s commercial launch capabilities and broader space technology operations.
As noted by Seeking Alpha, the analyst described Rocket Lab as a “core holding for space bulls,” adding that, “As one of the only companies on the planet delivering regular commercial access to orbit,” Rocket Lab is positioned to benefit from growth across the space industry.
Synspective Deal Expands Rocket Lab’s Launch Backlog
Synspective plans to use the launches to expand its StriX radar satellite network. Its goal is to build a constellation capable of imaging any location on Earth within hours, including at night and through clouds. Earth observation data can support disaster response, environmental monitoring, and national security, among other uses. Rocket Lab has previously highlighted those applications when discussing its work with Synspective.
Think about the challenge from the satellite operator’s perspective. Designing and building spacecraft is only part of the job. Those satellites also need to reach the right orbit on a schedule that supports the business. A dedicated launch service can help address that need. Customers are paying for access to orbit, but scheduling and mission requirements also matter.
In addition, Rocket Lab said the agreement pushed its total launch backlog beyond 100 missions. These missions extend through 2031, supporting a longer business relationship rather than a single burst of activity.
Revenue Growth Is Accelerating
In its most recent earnings report, the company’s EPS of negative eight cents was in line with expectations. Revenue of $234.06 million, up 62% year over year, beat by $3.12 million.
Rocket Lab founder and CEO, Sir Peter Beck, says: “Q2 was another fantastic quarter for Rocket Lab, highlighted by record results and massive momentum that has continued well after the close. We achieved a record $234 million in Q2 revenue – up 62% year-over-year and $34 million higher than last quarter’s record – driven by surging demand across all areas of our business. Q2 2026 saw our backlog grow to $2.36 billion – another record – which, combined with new deals in the period since, equates to more than $1 billion in new contracts across launch and space systems already entered into in Q3.”
RKLB Stock Tests Key Technical Levels
RKLB stock has rebounded sharply from its September low, but the chart shows that RKLB is still working through a significant technical test. Shares closed at $69.68 on Sept. 30, after reaching $75.46 on Sept. 24 and pulling back toward the $70 area. The stock’s recent price action has therefore created a near-term range between roughly $69 and $75.
The $75 area is the first important resistance level to watch. A decisive move above that zone would take RKLB back above its recent September highs. On the downside, the $69-$70 area has become important support, with the stock repeatedly trading around that level in recent sessions.
The longer-term chart remains more complicated. Current technical data put the 50-day simple moving average around $69.67, while the 100-day and 200-day averages are substantially higher at roughly $87.79 and $81.28, respectively. That suggests the recent recovery has improved the shorter-term setup, but RKLB still has longer-term technical hurdles to overcome.
Momentum indicators are also mixed. RSI is near the neutral 50 level, while MACD readings are slightly negative, pointing to a market that has not yet established a clear directional trend.
Why Rocket Lab’s Backlog Matters for Investors
For investors, the biggest takeaway is that Rocket Lab is turning demand for satellite launches into long-term customer commitments. Synspective’s decision to book another 20 missions suggests confidence in the relationship and gives Rocket Lab more visibility into future business. It also strengthens the argument that dedicated small-satellite launches have an important place in the growing space industry.
Of course, winning contracts is only part of the equation. Rocket Lab still needs to deliver those missions reliably, control costs, and translate its expanding backlog into stronger financial results. With financial terms undisclosed, investors cannot yet judge how profitable this latest agreement will be.
Still, the deal gives shareholders a concrete reason for optimism. Combined with Citi’s bullish outlook, it puts RKLB in the spotlight—and gives investors clear milestones to watch as the company works to turn a busy launch calendar into lasting growth.
